Amgen, Inc. (AMGN) Stock: Good Fundamentals, Good Yield, Good Opportunity

A combination of dividend, fundamental, technical and implied volatility analysis has uncovered a solid opportunity in AMGN. More 

IBB: The iShares NASDAQ Biotechnology Index (ETF) Is Still a Buy

Even if Hillary Clinton becomes the next POTUS, biotech stocks won't sink into oblivion -- that's enough reason to buy the IBB ETF. More 

The 10 Best Healthcare Stocks to Buy Now

These companies are 10 of the best healthcare stocks to buy right now, as they should outperform in 2016's second half thanks to a few near-term catalysts. More 

3 Great ETFs for a Biotech Rebound – BBP CNCR XBI

Biotech stocks and ETFs have recently been rebounding in impressive fashion. Tactical investors might want to take a look at BBP, XBI and CNCR. More 

Amgen, Inc. (AMGN) Earnings Prove It Should Be in Your Portfolio

AMGN stock is headed lower after earnings, but Q1 and guidance confirm that Amgen is a strong company, and well worth buying. More 

3 Stocks to Watch on Friday: Amgen, Inc. (AMGN), Gilead Sciences, Inc. (GILD) and TiVo, Inc. (TIVO)

Amgen (AMGN) and Gilead Sciences (GILD) will be moving Friday on earnings news, while TiVo (TIVO) will get a modest buyout bump. More 

Trade of the Day: Pounce on AMGN Stock on a Pullback

A decline to the 200-day moving average would provide an excellent entry point in Amgen, Inc. More